Skip to main content
. 2022 Jul 15;36(8):877–896. doi: 10.1007/s40263-022-00936-y

Table 4.

Investigational neuraxial drugs

Drugs not approved for neuraxial use with limited clinical evidence Experimental drugs
Gabapentin [220] Substance P-saporin [221]
Adenosine [222] CGX-1160 [223]
Ketorolac [224] Xen2174 [225]
Calcitonin [226] Contulakin-G [227]
Octreotide [228] Muscimol [229]
HTX-011 [230]
Resiniferatoxin [231]
Droperidol [113]

NMDA N-methyl-d-aspartate